These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30447113)

  • 1. LncRNA LINC00974 activates TGF-β/Smad signaling to promote oral fibrogenesis.
    Fang CY; Yu CC; Liao YW; Hsieh PL; Lu MY; Lin KC; Wu CZ; Tsai LL
    J Oral Pathol Med; 2019 Feb; 48(2):151-158. PubMed ID: 30447113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition.
    Lin CY; Hsieh PL; Liao YW; Peng CY; Yu CC; Lu MY
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis.
    Yu CC; Liao YW; Hsieh PL; Chang YC
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glabridin inhibits the activation of myofibroblasts in human fibrotic buccal mucosal fibroblasts through TGF-β/smad signaling.
    Lee PH; Chu PM; Hsieh PL; Yang HW; Chueh PJ; Huang YF; Liao YW; Yu CC
    Environ Toxicol; 2018 Feb; 33(2):248-255. PubMed ID: 29119715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC00312/YBX1 Axis Regulates Myofibroblast Activities in Oral Submucous Fibrosis.
    Yu CH; Fang CY; Yu CC; Hsieh PL; Liao YW; Tsai LL; Chu PM
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arecoline enhances miR-21 to promote buccal mucosal fibroblasts activation.
    Yang HW; Yu CC; Hsieh PL; Liao YW; Chu PM; Yu CH; Fang CY
    J Formos Med Assoc; 2021 Apr; 120(4):1108-1113. PubMed ID: 33191095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA GAS5-AS1 inhibits myofibroblasts activities in oral submucous fibrosis.
    Lin CY; Liao YW; Hsieh PL; Lu MY; Peng CY; Chu PM; Yang HW; Huang YF; Yu CC; Yu CH
    J Formos Med Assoc; 2018 Aug; 117(8):727-733. PubMed ID: 29249416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butylidenephthalide abrogates the myofibroblasts activation and mesenchymal transdifferentiation in oral submucous fibrosis.
    Su TR; Liao YW; Hsieh PL; Tsai LL; Fang CY; Lin T; Lee YH; Harn HJ; Yu CC
    Environ Toxicol; 2018 Jun; 33(6):686-694. PubMed ID: 29665273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2.
    Liao YW; Yu CC; Hsieh PL; Chang YC
    J Cell Mol Med; 2018 Sep; 22(9):4130-4138. PubMed ID: 29893466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing periostin inhibits myofibroblast transdifferentiation of fibrotic buccal mucosal fibroblasts.
    Su JY; Yu CC; Peng CY; Liao YW; Hsieh PL; Yang LC; Yu CH; Chou MY
    J Formos Med Assoc; 2021 Nov; 120(11):2010-2015. PubMed ID: 33965260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of miR-497 Attenuates Oral Submucous Fibrosis by Inhibiting Myofibroblast Transdifferentiation in Buccal Mucosal Fibroblasts.
    Huang J; Zhang H; Fan X; Guo J
    Oral Health Prev Dent; 2022 Aug; 20():339-348. PubMed ID: 35920886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts.
    Lu MY; Yu CC; Chen PY; Hsieh PL; Peng CY; Liao YW; Yu CH; Lin KH
    J Formos Med Assoc; 2018 Sep; 117(9):791-797. PubMed ID: 29958727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
    Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
    J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-10b regulated by Twist maintains myofibroblasts activities in oral submucous fibrosis.
    Fang CY; Yu CC; Liao YW; Hsieh PL; Ohiro Y; Chu PM; Huang YC; Yu CH; Tsai LL
    J Formos Med Assoc; 2020 Jul; 119(7):1167-1173. PubMed ID: 32265096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-424/TGIF2-Mediated Pro-Fibrogenic Responses in Oral Submucous Fibrosis.
    Chou MY; Hsieh PL; Chao SC; Liao YW; Yu CC; Tsai CY
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-1246 as a therapeutic target in oral submucosa fibrosis pathogenesis.
    Liu CM; Liao YW; Hsieh PL; Yu CH; Chueh PJ; Lin T; Yang PY; Yu CC; Chou MY
    J Formos Med Assoc; 2019 Jul; 118(7):1093-1098. PubMed ID: 30928188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slug mediates myofibroblastic differentiation to promote fibrogenesis in buccal mucosa.
    Fang CY; Hsia SM; Hsieh PL; Liao YW; Peng CY; Wu CZ; Lin KC; Tsai LL; Yu CC
    J Cell Physiol; 2019 May; 234(5):6721-6730. PubMed ID: 30230545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paeonol inhibits profibrotic signaling and HOTAIR expression in fibrotic buccal mucosal fibroblasts.
    Ho DC; Chen SH; Fang CY; Hsieh CW; Hsieh PL; Liao YW; Yu CC; Tsai LL
    J Formos Med Assoc; 2022 May; 121(5):930-935. PubMed ID: 34696937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of HIF1A-AS1 impedes the arecoline-induced migration activity of human oral mucosal fibroblasts.
    Wang YK; Liu CM; Lin T; Fang CY; Yu CC; Yu CH
    J Formos Med Assoc; 2020 Apr; 119(4):879-883. PubMed ID: 31959495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STRO-1 confers myofibroblast transdifferentiation in fibroblasts derived from oral submucous fibrosis.
    Yu CC; Liao YW; Yu CH; Chang YC
    J Oral Pathol Med; 2018 Mar; 47(3):299-305. PubMed ID: 29210111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.